Jul 2026· International Journal of Molecular Sciences· Vol 27, pp. 6574· 0 citations· 51 references
Medicine
TL;DR
The results showed that psychological distress, depression, and protein carbonyl content decreased significantly by discharge, and cortisol levels and telomere length showed no significant changes, demonstrating the feasibility of integrating psychological and molecular data to investigate biological response following SCI.
Abstract
This pilot study examined longitudinal changes in psychological distress and biomarkers related to stress, inflammation, and biological aging during the first inpatient rehabilitation after Spinal Cord Injury (SCI). We analyzed data from 120 participants in the SwiSCI inception cohort at two timepoints: the beginning of the first post-injury rehabilitation and discharge. A subset of 50 participants representing four distress patterns (high chronic, low, transient, increasing distress) underwent biomarker analyses, including measurements of immune and inflammatory proteins and whole-blood transcriptomic profiling. The results showed that psychological distress, depression, and protein carbonyl content decreased significantly by discharge. In contrast, cortisol levels and telomere length showed no significant changes. Proteomic analyses revealed a broad downregulation of inflammatory proteins (e.g., IFN-γ, IL-10, LIF) at discharge, whereas transcriptomic profiles did not differ between timepoints. The high chronic distress group showed lower expression of six genes involved in adaptive immunity, neural development and apoptosis. Psychological distress was not linearly associated with global biomarker profiles. However, CXCL1 and IL-7 showed low-to-moderate correlations with depression and anxiety, respectively. This pilot study demonstrates the feasibility of integrating psychological and molecular data to investigate biological response following SCI. The findings are exploratory and need validation in larger studies with longer follow-up periods.
Blood-based combinations of IFN-γ, IL-8 and IL-6 and CSF-based combinations of IFN-γ and IL-10 were associated with admission injury severity, and only GFAP in blood retained a consistent association with follow-up neurological status when accounting for admission injury severity.
K. A. Aagaard, T. O. Wichmann, C. V. B. Hviid et al.· Journal of Clinical Medicine· 0 citations
Neuromolecular biomarkers may improve the current symptom-based diagnostic model of PTSD and their integration with clinical assessment tools may support identification of biologically defined subgroups and enable more targeted treatment.
The findings support a biopsychosocial account in which biological injury mechanisms likely underpin sensory changes following msTBI, while psychological processes may differentially contribute to their expression, amplification, and maintenance.
J. Carmichael, M. Marzolla, G. Spitz et al.· Annals of Physical and Rehab...· 0 citations
The findings emphasise the potential of combining easily measurable predictors to enhance the early detection of PTSD risk and to guide the development of more personalised prevention and intervention strategies.
Mariana Xavier, I. Mocaiber, Orlando Fernandes et al.· European Journal of Psychotr...· 0 citations
The study highlights significant psychological challenges in individuals with TBI, emphasizing the role of emotional regulation in the co-occurrence of PTSS and depressive symptoms, and suggests that emotional regulation strategies play a crucial role in the psychological outcomes of TBI.
Iszati Afiqah Iskandar Zulkarnain, M. F. Mohd Zulkifly· IIUM Medical Journal Malaysi...· 0 citations
Serum taurine decreases following acute traumatic SCI, increases during recovery, and demonstrates good diagnostic performance with significant associations with functional outcomes, supporting its potential as a biomarker for injury severity and neurological recovery.
Zeenat Ara, S. Waliullah· European spine journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.